𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Potent in vitro and in vivo antitumor activity of sorafenib against human intrahepatic cholangiocarcinoma cells

✍ Scribed by Hiroaki Sugiyama; Kenichiro Onuki; Kazunori Ishige; Nobue Baba; Tetsuya Ueda; Sachiko Matsuda; Kaoru Takeuchi; Masafumi Onodera; Yasuni Nakanuma; Masayuki Yamato; Masakazu Yamamoto; Ichinosuke Hyodo; Junichi Shoda

Publisher
Springer Japan
Year
2011
Tongue
English
Weight
728 KB
Volume
46
Category
Article
ISSN
0944-1174

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Potent in vitro and in vivo antitumor ac
Potent in vitro and in vivo antitumor activity of interleukin-4-conjugated Pseudomonas exotoxin against human biliary tract carcinoma
✍ Kazunori Ishige; Junichi Shoda; Toru Kawamoto; Sachiko Matsuda; Tetsuya Ueda; Ic πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 French βš– 621 KB

## Abstract Targeting cytotoxins or immunotoxins to tumor cell surface receptors represents a new approach for the treatment of cancers. We tested the antitumor activity of a cytotoxin (IL‐4‐PE) composed of an interleukin‐4 (IL‐4) targeting moiety and a truncated form of __Pseudomonas__ exotoxin A

In vitro and In vivo antitumor activity
In vitro and In vivo antitumor activity of lymphokine-induced cytotoxic cells
✍ Chou-Chik Ting; John R. Wunderlich; Myrthel E. Hargrove; David Winkler πŸ“‚ Article πŸ“… 1985 πŸ› John Wiley and Sons 🌐 French βš– 690 KB

## Abstract The present study demonstrates that LICC possess both __in vitro__ and __in vivo__ antitumor activity. The LICC were generated by culturing normal spleen cells with syngeneic peritoneal cells and indomethacin, or with a conditioned medium containing IL 2 with or without a putative new l

Chimeric, divalent and tetravalent anti-
Chimeric, divalent and tetravalent anti-CD19 monoclonal antibodies with potent in vitro and in vivo antitumor activity against human B-cell lymphoma and pre-B acute lymphoblastic leukemia cell lines
✍ Xiao-Yun Liu; Laurentiu M. Pop; Lydia Tsai; Iliodora V. Pop; Ellen S. Vitetta πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 French βš– 295 KB

## Abstract CD19 is an attractive therapeutic target for treating human B‐cell tumors. In our study, chimeric (c) divalent (cHD37) and tetravalent (cHD37‐DcVV) anti‐CD19 monoclonal antibodies (MAbs) were constructed, expressed and evaluated for their binding to human 19‐positive (CD19^+^) tumor cel

In vitro and in vivo antitumor activity
In vitro and in vivo antitumor activity of liposomal fenretinide targeted to human neuroblastoma
✍ Lizzia Raffaghello; Gabriella Pagnan; Fabio Pastorino; Emilio Cosimo; Chiara Bri πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 French βš– 313 KB πŸ‘ 1 views

Neuroblastoma (NB) is the most common extracranial solid tumor of childhood. In advanced disease stages, prognosis is poor and treatments have limited efficacy, thus novel strategies are warranted. The synthetic retinoid Fenretinide (HPR) induces apoptosis in NB and melanoma cell lines. We reported